FIRST AMENDMENT TO AMENDED AND RESTATED FOUNDERS AGREEMENTFounders Agreement • November 3rd, 2017 • Checkpoint Therapeutics, Inc. • Pharmaceutical preparations • New York
Contract Type FiledNovember 3rd, 2017 Company Industry JurisdictionThis FIRST AMENDMENT TO AMENDED AND RESTATED FOUNDERS AGREEMENT (this “Amendment”) is effective as of this 5th day of October 2017 (the “Effective Date”) between Fortress Biotech, Inc., a Delaware corporation (the “Founder”), and Checkpoint Therapeutics, Inc., a Delaware corporation (the “Company”).